GlassScriptPhysician profile
Saad Tabbara
NPI 1518993542
$28,117.98
in general payments reported to CMS, 2019-2025
34 companies · $5,209 in 2025
The $5,209 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,606 · 2020: $505 · 2021: $3,480 · 2022: $3,400 · 2023: $11K · 2024: $3,330 · 2025: $5,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Food and Beverage: $7,898 · Travel and Lodging: $2,081 · Consulting Fee: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Food and Beverage | $7,897.77 |
| Travel and Lodging | $2,081.17 |
| Consulting Fee | $148.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13,232.90 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $3,232.80 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Penumbra, INC. | $1,888.36 | 2022 | |
| Teleflex LLC | $1,511.69 | 2024-2025 | Guideliner, Turnpike, Supercross |
| Medtronic, INC. | $1,285.38 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $1,067.20 | 2019-2025 | Coroflow, Xact, Navitor |
| Boston Scientific Corporation | $939.54 | 2019-2025 | Opticross, Watchman Flx, Avvigo Guidance System |
| Medtronic Vascular, INC. | $635.32 | 2019-2020 | |
| Abiomed | $605.05 | 2019-2024 | Impella |
| Impulse Dynamics (USA) INC. | $412.50 | 2021-2024 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $396.50 | 2021-2025 | Farxiga, Lokelma |
| Stryker Corporation | $395.24 | 2025 | Venacore Thrombectomy Catheter, Artix Mt, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $394.00 | 2019-2025 | |
| Inari Medical, INC. | $279.33 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $195.28 | 2019-2024 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiac Dimensions, INC. | $171.64 | 2024 | |
| Cook Medical LLC | $165.91 | 2019 | |
| Jenavalve Technology, INC. | $148.08 | 2024 | |
| W. L. Gore & Associates, INC. | $126.59 | 2021 | |
| Pfizer INC. | $126.25 | 2019-2025 | |
| Tactile Systems Technology INC | $124.08 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Altathera Pharmaceuticals LLC | $123.33 | 2023 | Sotalol Hydrochloride |
| Heartflow, INC. | $117.95 | 2025 | |
| Celonova Biosciences, INC. | $88.54 | 2021 | |
| Amgen INC. | $85.42 | 2019-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $79.15 | 2024-2025 | Eliquis |
| Angiodynamics, INC. | $75.96 | 2021 | |
| Novo Nordisk INC | $64.83 | 2023 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.78 | 2019-2024 | Jardiance |
| Esperion Therapeutics, INC. | $20.88 | 2025 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $20.31 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $18.04 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $16.46 | 2024 | |
| Cardiva Medical, INC. | $15.69 | 2025 | Savvywire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,150.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saad Tabbara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.